Federated Hermes
CTIC

Federated Hermes’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Federated Hermes’s Portfolio CTIC Stock Details CTIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1
Closed -$1K – 2347
2022
Q3 		$1K Sell
1
-187
-99% -$1.17K ﹤0.01% 2131
2022
Q2 		$1K Buy
+188
New +$963 ﹤0.01% 2126
2020
Q3 		– Sell
-209
Closed -$1K – 2428
2020
Q2 		$1K Sell
209
-458
-69% -$484 ﹤0.01% 2223
2020
Q1 		$1K Hold
667
– – ﹤0.01% 2223
2019
Q4 		$1K Hold
667
– – ﹤0.01% 2196
2019
Q3 		$1K Sell
667
-1,344
-67% -$1.03K ﹤0.01% 2187
2019
Q2 		$2K Hold
2,011
– – ﹤0.01% 2094
2019
Q1 		$2K Hold
2,011
– – ﹤0.01% 2089
2018
Q4 		$1K Hold
2,011
– – ﹤0.01% 2179
2018
Q3 		$4K Sell
2,011
-436
-18% -$1.08K ﹤0.01% 2102
2018
Q2 		$12K Buy
2,447
+1,183
+94% +$5.18K ﹤0.01% 1888
2018
Q1 		$5K Buy
+1,264
New +$4.45K ﹤0.01% 1983

Other funds holding CTIC

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $114M AUM 77.6% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2B AUM 117.41% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return